WebApr 27, 2024 · On average, analysts give CTSO a Strong Buy rating. The average price target is $10.166, which means analysts expect the stock to add by 384.10% over the next twelve months. That average ranking earns CTSO an Analyst Rating of 72, which is better than 72% of stocks based on data compiled by InvestorsObserver. WebCTSO Valuation Summary. CTSO's price/earnings ratio is -3.7; this is 115.81% lower than that of the median Healthcare stock. Over the past 184 months, CTSO's EV/EBIT ratio has gone down 1.8. Below are key valuation metrics over time for CTSO. Stock.
CTSO - Cytosorbents Corporation Stock Price and Quote
WebApr 6, 2024 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Cytosorbents stock is Buy based on the current 1 buy rating for CTSO. The … Web$CTSO Entry price : 11.48 Fundamentals : - Sector: Medical Products - EPS % Chg (Last Qtr): 90% - EPS % Chg (Previous Qtr): 29% - 3 Year EPS Growth Rate: 0% - EPS Est % Chg (Current Yr): 0% - Sales % Chg (Last … text and tests 1 ebook
Cytosorbents Corp (CTSO) Up 1.64% in Premarket Trading
WebOct 18, 2008 · Cytosorbents Corporation (CTSO) Message Board - Company Name: Cytosorbents Corporation , Stock Symbol: CTSO, Industry: Medical - Equipment - Total Posts: 27307 - Last Post: 04/08/2024 06:12:15 PM - company/specific stock board. Support: 888-992-3836 Home NewsWire Subscriptions ... Detailed Quote . CTSO Latest … WebApr 11, 2024 · CTSO Cytosorbents CorporationStock Price & Overview. $3.37 -0.06 ( -1.75%) 4:00 PM 03/31/23. NASDAQ $USD Post-Market: $3.37 5:09 PM. Summary. … WebSep-14-22 06:39AM. Great news for Cytosorbents Corporation (NASDAQ:CTSO): Insiders acquired stock in large numbers last year. Simply Wall St. Sep-09-22 07:00AM. The U.S. Department of Defense Awards CytoSorbents an Approximately $2.0M Contract to Support HemoDefend-BGA Development for Life-saving Universal Plasma. text and test 2